Company Profile
Evogene Stock Price, News & Analysis
- Ticker:
- EVGN
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Israel
Stock performance
0.69 USD (+8.56%)
Close
Last updated: August 6, 2026
6.14M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, EVGN closed up 8.56% at $0.6850. No new same-company headline was identified in the current news window.
Company overview
Business overview
Evogene is a computational biology and platform company focused on using data science to design biological products across agriculture and life sciences. Its business is more about biological engineering than drug development.
Geographic Base and Sector Classification
Evogene is headquartered in Israel and listed on NASDAQ. It sits in biotechnology tools and computational biology.
Business Model Characteristics
The company depends on platform adoption, strategic partnerships, and the ability to monetize computational biology across multiple end markets. Investors watch collaborations, platform breadth, and commercial execution.
Position Within the Biotechnology Landscape
Evogene occupies a platform-biology niche rather than a classic therapeutics role. It matters to the broader biotech ecosystem because it enables biological design and discovery.
Future catalysts
Evogene’s catalysts are platform execution across ag-biotech and pharma discovery, plus any update that shows its computational biology approach can keep producing value. The market will watch whether the platform remains relevant.
Recent news
- 01
- 02
- 03
- 04
- 05
Evogene Reports Third Quarter 2018 Financial Results
Source: Evogene
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Evogene (EVGN)?
Evogene (EVGN) most recently closed at 0.69 USD, a +8.56% move versus the previous session.
What is the market cap of Evogene (EVGN)?
Evogene currently has a market capitalization of 6.14M USD on BioPharmSignal.
What does Evogene do?
Evogene is a computational biology and platform company focused on using data science to design biological products across agriculture and life sciences. Its business is more about biological engineering than drug development.
On which exchange is EVGN stock listed?
Evogene (EVGN) is associated with NASDAQ, Israel, Biopharma.
What is Evogene?
Evogene’s catalysts are platform execution across ag-biotech and pharma discovery, plus any update that shows its computational biology approach can keep producing value.
Which conditions is Evogene targeting with Evogene?
Evogene’s catalysts are platform execution across ag-biotech and pharma discovery, plus any update that shows its computational biology approach can keep producing value.
How does Evogene describe recent progress with Evogene?
Evogene’s catalysts are platform execution across ag-biotech and pharma discovery, plus any update that shows its computational biology approach can keep producing value.
What future catalysts are investors watching for Evogene?
Evogene’s catalysts are platform execution across ag-biotech and pharma discovery, plus any update that shows its computational biology approach can keep producing value. The market will watch whether the platform remains relevant.